How much would you pay for the tremor-reducing GyroGlove?

News

Author: Geoffrey ChangPublished: 7 October 2016

Prep: Cook: Serves:

Developments have been made on GyroGlove – the innovative tremor-reducing glove – and now the GyroGear team behind the technology are asking the Parkinson’s community to complete a survey on the pricing of their device. The survey takes five minutes to complete and is anonymous. Your views and insights from the survey will help inform the pricing of the glove.

“The data will allow us to push for the most reasonable price without compromising on quality. It will inform which components we choose, where we manufacture, and how we design in order to make the GyroGlove an affordable and useful purchase,” say the team. “This information is going to be pivotal in the coming months, as we finalise device specifications.”

This latest move suggests GyroGlove is in the final stages of development and that it won’t be long until the product hit the shelves.

The survey will be available until 12 October.

Last Month

Next Month

Go Back

Share this story

Comments

Interviews

Why I set up a Parkinson’s support group that’s just for women

Women-only group openly talks about sexuality & other issues

“The injustice of Parkinson’s motivates me”

We talk to adventurer Alex Flynn about his incredible achievements

‘No Time Like the Future’: Michael J Fox announces new book

The fourth book by the US actor and Parkinson’s campaigner

Can tremor predict the effect of Parkinson’s disease medication?

Researchers from the Netherlands have found a link between tremor symptoms and how dopaminergic medication impacts learning abilities in Parkinson’s disease. Many people with Parkinson’s become sensitive to learning through rewards due to a decrease in dopamine in the brain. As part of a new study – published in the scientific journal Brain –researchers assessed 43 tremor-dominant and 20 non-tremor dominant people with Parkinson’s while they were on and off dopaminergic medication. The results showed that in people with Parkinson’s who do not experience tremor, dopaminergic medication improves the ability to learn from rewards – and in those with tremor, the medication has no impact on reward learning. Rick Helmich, co-author of the study and a neurologist at Radboud University Medical Centre, the Netherlands, said: “Whether someone experiences tremor or not might therefore potentially have a significant predictive value regarding the effectiveness of medication in the cognitive domain. However, more…

Could a ‘Mediterranean diet’ lower the risk of Parkinson’s for women?

A study by scientists in Sweden has suggested that women who eat a ‘Mediterranean diet’ at middle age could have a lower risk of Parkinson’s later in life. The report, published in the Movement Disorders journal, used dietary information from more than 47,000 women aged 29 to 49, recorded between the early 1990s and 2012. They looked at how closely the women adhered to a Mediterranean dietary pattern (MDP), which is high in foods such as vegetables, fruits, nuts, unsaturated fats and legumes. They then compared the information with data from the Swedish National Patient Register to find out whether participants had been diagnosed with Parkinson’s. The researchers found that those with a high adherence to the diet had a 46% lower risk of being diagnosed with the condition compared to those with a low adherence, concluding that “higher adherence to a Mediterranean diet at middle age was associated with…

Pesticide that increases Parkinson’s risk by 150% reapproved in the US

The US Environmental Protection Agency (EPA) has allowed the continued use of paraquat, a pesticide that increases the risk of Parkinson’s disease by 150%. The pesticide – which has already been banned in 32 countries – was reapproved by the EPA in October as part of a review of the safety of all herbicides and pesticides in the US, a process which takes place every 15 years. Many studies have shown that as well as increased risk of Parkinson’s disease, exposure to the pesticide is associated with other health issues and risk of death. Exposure to paraquat endangers both the farmers who use the pesticide, as well as the families who can be exposed to it through the air or transfers onto clothing or other materials. In response to the reapproval, the Michael J Fox Foundation is calling on the Parkinson’s community to ask senators and representatives to support a…

All fields required

First name*
Last name*
Email address*
Enter Email Confirm Email
Country of residence*
About me*
- I have Parkinson's disease
- I am a partner / carer / family / friend of someone who has Parkinson's
- I am a healthcare professional with an interest in Parkinson's
- I work for a Parkinson's disease organisation
- Other
CAPTCHA
*
- By proceeding you agree to our
Comments
This field is for validation purposes and should be left unchanged.

How much would you pay for the tremor-reducing GyroGlove?

News

Author: Geoffrey ChangPublished: 7 October 2016

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Interviews

Why I set up a Parkinson’s support group that’s just for women

Interviews

“The injustice of Parkinson’s motivates me”

Global update

‘No Time Like the Future’: Michael J Fox announces new book

Can tremor predict the effect of Parkinson’s disease medication?

Could a ‘Mediterranean diet’ lower the risk of Parkinson’s for women?

Pesticide that increases Parkinson’s risk by 150% reapproved in the US

{title}

Subscribe

How much would you pay for the tremor-reducing GyroGlove?

News

Author: Geoffrey ChangPublished: 7 October 2016

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Related articles

Interviews

Why I set up a Parkinson’s support group that’s just for women

Interviews

“The injustice of Parkinson’s motivates me”

Global update

‘No Time Like the Future’: Michael J Fox announces new book

Can tremor predict the effect of Parkinson’s disease medication?

Could a ‘Mediterranean diet’ lower the risk of Parkinson’s for women?

Pesticide that increases Parkinson’s risk by 150% reapproved in the US

{title}

Subscribe

Sign in